Presented at #ASCO26:
Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: https://t.co/xwLWBZYRzq
@ASCO
#AITHYRA is born! 🎉 OeAW is founding a new institute at the intersection of #AI & #biomedicine – the AITHYRA Institute. Meet the new founding director and DeepMind Professor of Artificial Intelligence @mmbronstein. Watch now ➡️https://t.co/rMlhu7GsaV #boehringeringelheimstiftung
Congrats to Viktoria @HolzmannV PhD (@NRivron Lab), who defended her thesis: Use of embryonic & extra-embryonic stem cells to infer the signalling interactions directing differentiation & morphogenesis during implantation stages. @univienna@IMPvienna@IMBA_Vienna@gmivienna
Esther Uijttewaal, PhD student in the lab of Ulrich Elling at IMBA, successfully defended her PhD thesis about “Advancing CRISPR technologies, from controlled sgRNA activation to innovative in vivo screening”. Congratulations Esther! @E_Uijttewaal@TrainingVbc
Viktoria @HolzmannV recently defended her thesis on the use of embryonic and extra-embryonic stem cells to infer the signalling interactions directing differentiation and morphogenesis during embryo implantation. Congratulations Viktoria! @TrainingVbc
Next Elling lab celebration: Dr. Joonsun Lee @joonsunlee congratulations to your PhD! Well done, well deserved! You overcame many hurdles with your positive spirit and determination, amazing! And you succeeded in tackling one of the hardest challenges in functional genetics! 👏🏻👏🏻
Congratulations, Dr. @E_Uijttewaal , for the successful completion of your PhD in our lab at @IMBA_Vienna /@oeaw ! 🥳🎉🍾Well done!
You really delivered a solution to a long-standing problem in high throughput functional genomics that will gain lots of attention. 👏👏👏
Elly Tanaka will be IMBA’s new Scientific Director, heading the institute from April 2024 onwards. Elly Tanaka is a renowned researcher, who studies the regeneration of complex body parts. Welcome, Elly!
After +7 highly successful years as IMP Senior Group Leader, Elly Tanaka (@Tanaxolotl) will leave us to become Scientific Director of @IMBA_Vienna. IMP management is excited about the opportunities for furthering campus cohesion at @viennabiocenter.
https://t.co/lpv1IFa1RS
We are excited to announce the 2024 SY-Stem Symposium for Stem Cell Biology. The meeting will take place as an in-person event at the Vienna BioCenter. Further details are available online: https://t.co/u5dkeTZ4Rm @IMPvienna
[SY-Stem 2024]
We will have another SY-Stem meeting in Vienna! Please find the list of confirmed speakers. I also welcome everybody who likes stem cells to join us!
Here is the link to registration: https://t.co/S2wwouYQPN
🌟 Farewell, BK and team! 🌟 Our Friday social hour, the final one sponsored by the Koo lab, was a beautiful send-off. Thank you for the laughter, collaboration, and inspiration. Best wishes to all! #FarewellKooLab
Since the discovery of CRISPR-Cas systems, people have wondered if a similar type of system exists in eukaryotes. Today, we report in @Nature the characterization of Fanzor, a eukaryotic RNA-guided system that can be reprogrammed for human genome editing. https://t.co/aKLMMEBRkk
Big congratulations to Elly Tanaka (@Tanaxolotl), who was elected to the US National Academy of Sciences (@theNASciences)! Elly is one of 120 newly elected members, IMP emeritus director Kim Nasmyth one of 23 new international members. More: https://t.co/VXILPV5puT